1 – 35 of 35
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
- 2019
-
Mark
Prediction of lymph node metastasis in breast cancer by gene expression and clinicopathological models: Development and validation within a population based cohort.
(
- Contribution to journal › Article
- 2018
-
Mark
Clinical Value of RNA Sequencing–Based Classifiers for Prediction of the Five Conventional Breast Cancer Biomarkers: A Report From the Population-Based Multicenter Sweden Cancerome Analysis Network—Breast Initiative
(
- Contribution to journal › Article
-
Mark
Abstract P4-09-03: On the development and clinical value of RNA-sequencing-based classifiers for prediction of the five conventional breast cancer biomarkers: A report from the population-based multicenter SCAN-B study
(
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
An integrated genomics analysis of epigenetic subtypes in human breast tumors links DNA methylation patterns to chromatin states in normal mammary cells.
(
- Contribution to journal › Article
- 2015
-
Mark
Remarkable similarities of chromosomal rearrangements between primary human breast cancers and matched distant metastases as revealed by whole-genome sequencing.
(
- Contribution to journal › Article
-
Mark
Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Molecular stratification of metastatic melanoma using gene expression profiling: prediction of survival outcome and benefit from molecular targeted therapy.
(
- Contribution to journal › Article
-
Mark
Whole genome sequencing of primary breast cancers and matched distant metastases
2015) American Association for Cancer Research (AACR) 106th Annual Meeting 2015 In Cancer Research 75(15).(
- Contribution to journal › Published meeting abstract
-
Mark
Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.
(
- Contribution to journal › Article
- 2013
-
Mark
Histological specificity of alterations and expression of KIT and KITLG in non-small cell lung carcinoma.
(
- Contribution to journal › Article
-
Mark
Detecting EGFR alterations in clinical specimens-pitfalls and necessities.
(
- Contribution to journal › Article
- 2012
-
Mark
Molecular profiling reveals low- and high-grade forms of primary melanoma
(
- Contribution to journal › Article
-
Mark
Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes.
(
- Contribution to journal › Article
- 2011
-
Mark
CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
(
- Contribution to journal › Article
- 2010
-
Mark
Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families
(
- Contribution to journal › Article
-
Mark
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
(
- Contribution to journal › Article
- 2009
-
Mark
Comparison of cisplatin sensitivity and the 18F fluoro-2-deoxy 2 glucose uptake with proliferation parameters and gene expression in squamous cell carcinoma cell lines of the head and neck
(
- Contribution to journal › Article
-
Mark
Indistinguishable genomic profiles and shared prognostic markers in undifferentiated pleomorphic sarcoma and leiomyosarcoma: different sides of a single coin?
(
- Contribution to journal › Article
- 2008
-
Mark
The CD44(+)/CD24(-) phenotype is enriched in basal-like breast tumors
(
- Contribution to journal › Article
- 2007
-
Mark
Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers
(
- Contribution to journal › Article
-
Mark
Estrogen receptor beta expression is associated with tamoxifen response in ER alpha-negative breast carcinoma
(
- Contribution to journal › Article
-
Mark
Genomic profiling of malignant melanoma using tiling-resolution arrayCGH.
(
- Contribution to journal › Article
-
Mark
Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity
(
- Contribution to journal › Article
-
Mark
Cytogenetic characterization and gene expression profiling of the trastuzumab-resistant breast cancer cell line JIMT-1.
(
- Contribution to journal › Article
- 2005
-
Mark
Mapping of a novel ocular and cutaneous malignant melanoma susceptibility locus to chromosome 9q21.32.
(
- Contribution to journal › Article
- 2003
-
Mark
Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.
(
- Contribution to journal › Article
- 2002
-
Mark
Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis
(
- Contribution to journal › Article
-
Mark
TP53 protein expression analysis by luminometric immunoassay in comparison with gene mutation status and prognostic factors in early stage endometrial cancer
(
- Contribution to journal › Article
- 2001
-
Mark
Haplotype analysis and age estimation of the 113insR CDKN2A founder mutation in Swedish melanoma families
(
- Contribution to journal › Article
- 2000
-
Mark
Prognosis and clinical presentation of BRCA2-associated breast cancer
(
- Contribution to journal › Article
- 1998
-
Mark
Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes
(
- Contribution to journal › Article
- 1997
-
Mark
Identification of TP53 gene mutations in uterine corpus cancer with short follow-up
(
- Contribution to journal › Article
- 1996
-
Mark
Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay
(
- Contribution to journal › Article
- 1995
-
Mark
Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation
(
- Contribution to journal › Article